Results 1 to 10 of about 89,546 (321)

Epidemiological profile of arboviruses in two different scenarios: dengue circulation vs. dengue, chikungunya and Zika co-circulation

open access: yesBMC Infectious Diseases, 2023
Highlights The introduction of chikungunya and Zika viruses did not change the epidemiological profile of dengue cases in our study population. Most cases of dengue, chikungunya and Zika have been described in women. Dengue, chikungunya and/or Zika cases
Pablo Cantalice Santos Farias   +8 more
doaj   +1 more source

Anti-viral activity of Zingiber officinale (Ginger) ingredients against the Chikungunya virus

open access: yesVirusDisease, 2020
Chikungunya is one of the highly infectious viral disease without vaccine and anti-viral. Aim of present study is to check the anti-chikungunya activities of Zingiber officinale (Ginger) in the animal cell culture model.
S. Kaushik   +4 more
semanticscholar   +1 more source

Continuous Circulation of Chikungunya Virus during COVID-19 Pandemic in Jambi, Sumatra, Indonesia

open access: yesTropical Medicine and Infectious Disease, 2022
Chikungunya fever is a self-limiting viral illness that is caused by the chikungunya virus (CHIKV). CHIKV is found in multiple provinces of Indonesia, with clustered local outbreaks.
Marsha Sinditia Santoso   +8 more
doaj   +1 more source

In-vitro and in-silico evaluation of the anti-chikungunya potential of Psidium guajava leaf extract and their synthesized silver nanoparticles

open access: yesVirusDisease, 2021
Chikungunya is a notorious viral infection, which affects a large segment of world populations in absence of vaccines and antivirals. The current study evaluates of anti-chikungunya activities of Psidium guajava leaves extract and their green synthesized
Yashika Sharma   +6 more
semanticscholar   +1 more source

Explorations on the antiviral potential of zinc and magnesium salts against chikungunya virus: implications for therapeutics

open access: yesFrontiers in Cellular and Infection Microbiology
BackgroundChikungunya virus (CHIKV), which causes chikungunya fever, is an arbovirus of public health concern with no approved antiviral therapies. A significant proportion of patients develop chronic arthritis after an infection.
Kusuma Sai Davuluri   +8 more
doaj   +1 more source

Genetic predisposition to chikungunya – a blood group study in chikungunya affected families

open access: yesVirology Journal, 2009
Chikungunya fever is a viral disease transmitted to humans by the bite of CHIKV virus infected Aedes mosquitoes. During monsoon outbreak of chikungunya fever, we carried out the genetic predisposition to chikungunya in disease affected 100 families by ...
Ramakrishna Vadde   +2 more
doaj   +1 more source

Impact of concurrent epidemics of dengue, chikungunya, zika, and COVID-19

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2021
INTRODUCTION: This study evaluated the epidemiological implications of arbovirus infections and coronavirus disease (COVID-19) co-occurrences in Espírito Santo, Brazil.
Creuza Rachel Vicente   +3 more
semanticscholar   +1 more source

Analysis of the dynamics of a vector-borne infection with the effect of imperfect vaccination from a fractional perspective

open access: yesScientific Reports, 2023
The burden of vector-borne infections is significant, particularly in low- and middle-income countries where vector populations are high and healthcare infrastructure may be inadequate.
Tao-Qian Tang   +5 more
doaj   +1 more source

Neutrophil Extracellular Traps Effectively Control Acute Chikungunya Virus Infection

open access: yesFrontiers in Immunology, 2020
The Chikungunya virus (CHIKV) is a re-emerging arbovirus, in which its infection causes a febrile illness also commonly associated with severe joint pain and myalgia.
Carlos H. Hiroki   +7 more
semanticscholar   +1 more source

Durability of Functional SARS-CoV-2-Specific Immunological Memory and T Cell Response up to 8–9 Months Postrecovery From COVID-19

open access: yesJournal of Immunology Research
Research on long-term follow-up in individuals who have recovered from coronavirus disease-19 (COVID-19) would yield insights regarding their immunity status and identify those who need booster vaccinations.
Diptee Trimbake   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy